Streetbeat News

Earnings

MSGE

Madison Square Garden Entertainment (MSGE) reported a Q1 loss of $0.40 per share, which was better than the Zacks Consensus Estimate of a $0.78 loss. This is an improvement from the $0.73 loss per share reported a year ago.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

SOLV

Solventum's Q3 earnings and sales exceeded estimates, driven by pricing normalization and increased demand for MedSurg products. The company also raised its 2024 outlook.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

TNDM

Tandem Diabetes (TNDM) reported better-than-expected Q3 earnings, driven by strong demand for its t:slim X2 and Tandem Mobi products. Despite the positive earnings, the stock fell in aftermarket trading.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

QCOM

Qualcomm's Q4 earnings report shows strong financial performance with over $10 billion in revenue and a P/E ratio in the high teens. The company forecasts nearly $11 billion in revenue and EPS approaching $12/share, driven by strong margins and reduced share count. Qualcomm leads in Snapdragon processors, automotive intelligence, and Wi-Fi 7, despite risks from potential Intel acquisition and Arm lawsuit.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

HIPO

Hippo Holdings Inc. (HIPO) reported a Q3 loss of $0.34 per share, which is better than the Zacks Consensus Estimate of a $1 loss. This is an improvement from the $2.24 loss per share a year ago.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

MYGN

Myriad Genetics (MYGN) reported strong third-quarter earnings and revenue growth, driven by its Pharmacogenomics and Prenatal segments. The company has also raised its full-year EPS guidance for 2024.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

NRG

NRG Energy reported Q3 earnings of $1.85 per share, missing the Zacks Consensus Estimate of $2.05. This is an increase from $1.62 per share a year ago.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

BLK

LLY

MU

Micron Technology leads the S&P 500 as one of the top performers this earnings season, with significant sales growth and improved profit margins. BlackRock and Eli Lilly also show strong sales growth and margin improvements.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

EBS

Emergent BioSolutions' stock surged by 20% following its Q3 earnings report, with shares now valued at approximately $11. The company's market cap is around $595 million, indicating strong investor confidence.

Portfolio Pulse from

November 08, 2024 | 2:45 pm

RUN

Sunrun's latest earnings report provides positive insights for the solar industry, indicating potential recovery for solar stocks.

Portfolio Pulse from

November 08, 2024 | 2:30 pm